Status:
UNKNOWN
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract
Lead Sponsor:
Chakshu Research, Inc.
Conditions:
Cataract
Eligibility:
All Genders
50-85 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the safety and efficacy of C-KAD Ophthalmic Solution in improving visual acuity relative to placebo in patients with age-related cataract
Eligibility Criteria
Inclusion
- Presence of age-related cataract in the study eye
- Best-corrected visual acuity of 20/25 to 20/50 in the study eye
Exclusion
- Any other clinical condition in the eye that may compromise vision
- Presence or History of Glaucoma
- Presence or history of diabetes
- Use of eyedrops
- Use of steroids
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00793091
Start Date
November 1 2008
End Date
September 1 2009
Last Update
November 27 2008
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Pacific Eye Specialists
San Francisco, California, United States, 94115
2
Hunkeler Eye Institute
Overland Park, Kansas, United States, 66210
3
Minnesota Eye Consultants, PA
Minneapolis, Minnesota, United States, 55405
4
Charlotte Eye, Ear, Nose & Throat Associates
Charlotte, North Carolina, United States, 28210